A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
Sponsor
Alcon Research (Industry)
Overall Status
Completed
CT.gov ID
NCT00326092
Collaborator
(none)
88
1
3
29.1
Study Details
Study Description
Brief Summary
The purpose of this study is to assess the comfort of a glaucoma therapy in patients with open-angle glaucoma or ocular hypertension
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
| Phase 2 |
Study Design
Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
Study Start Date
:
May 1, 2006
Actual Primary Completion Date
:
Aug 1, 2006
Actual Study Completion Date
:
Aug 1, 2006
Outcome Measures
Primary Outcome Measures
- Ocular discomfort []
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Adults of either sex and any race diagnosed with open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component)
Exclusion Criteria:
- Under 18
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Fort Worth and Other Sites | Fort Worth | Texas | United States | 76134 |
Sponsors and Collaborators
- Alcon Research
Investigators
- Study Director: Julia White, Study Director
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Alcon Research
ClinicalTrials.gov Identifier:
NCT00326092
Other Study ID Numbers:
- C-05-49
First Posted:
May 16, 2006
Last Update Posted:
Nov 18, 2016
Last Verified:
Sep 1, 2007
Additional relevant MeSH terms: